These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 3154465

  • 41. Experience with early quadruple immunosuppressive therapy in heart transplantation.
    Goenen M, Col J, Baele P, Latinne D, Noel H, Alexandre G, Schoevardts JC, Ponlot R, Chalant C.
    Bibl Cardiol; 1988; (43):23-6. PubMed ID: 3067718
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The Stanford experience: survival and renal function in the pre-sandimmune era compared to the sandimmune era.
    Hunt SA, Gamberg P, Stinson EB, Oyer PE, Shumway NE.
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):1-5. PubMed ID: 2349732
    [No Abstract] [Full Text] [Related]

  • 46. [Preventive administration of antithymocyte globulin in combined immunosuppressive therapy with cyclosporin A, azathioprine and prednisone in kidney transplantation].
    Matl I, Kaslíková J, Jirka J.
    Cas Lek Cesk; 1991 Mar 22; 130(12):364-6. PubMed ID: 2032265
    [Abstract] [Full Text] [Related]

  • 47. Effect of initial versus delayed cyclosporine therapy in cadaveric renal transplant patients.
    Lewis R, Hodge E, Novick A, Steinmuller D, Streem S, Cunningham R, Swift C, Goormastic M, Badhwar K.
    Transplant Proc; 1987 Feb 22; 19(1 Pt 3):2088-92. PubMed ID: 3029914
    [No Abstract] [Full Text] [Related]

  • 48. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS, Samhan M, John P, al-Adnani MS, Abouna GM.
    Transplant Proc; 1989 Feb 22; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract] [Full Text] [Related]

  • 49. A controlled trial of antihuman lymphocyte globulin (Behring) in cadaveric renal transplantation: improvement in graft and patient survival at one year using a high-dose regimen.
    Groth CG, Berg B, Collste H, Lundgren G, Magnusson G, Ringdén O, Pieper R.
    Scand J Urol Nephrol Suppl; 1977 Feb 22; (42):83-5. PubMed ID: 356230
    [Abstract] [Full Text] [Related]

  • 50. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D, Marsden J, Palmer A, Cairns T, Johnston A, Holt DW.
    Transplant Proc; 1990 Jun 22; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract] [Full Text] [Related]

  • 51. Late cyclosporine conversion carries risk of irreversible rejection.
    Sagalowsky AI, Reisman ME, Dawidson I, Toto R, Peters PC, Helderman JH.
    Transplant Proc; 1988 Jun 22; 20(3 Suppl 3):157-60. PubMed ID: 3291233
    [No Abstract] [Full Text] [Related]

  • 52. Treatment of chronic renal allograft rejection with cyclosporine and prednisone.
    Rosenblum ND, Harmon WE, Levey RH.
    Transplantation; 1988 Jan 22; 45(1):232-4. PubMed ID: 3276052
    [No Abstract] [Full Text] [Related]

  • 53. A randomized study comparing high- and low-dose regimens of cyclosporine in renal transplantation.
    Kootte AM, Lensen LM, van Bockel JH, Paul LC.
    Transplant Proc; 1988 Jun 22; 20(3 Suppl 3):136-9. PubMed ID: 3291227
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Reduction of infectious complications following heart transplantation with triple-drug immunotherapy.
    Andreone PA, Olivari MT, Elick B, Arentzen CE, Sibley RK, Bolman RM, Simmons RL, Ring WS.
    J Heart Transplant; 1986 Jun 22; 5(1):13-9. PubMed ID: 3302153
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients.
    Kupin W, Venkat KK, Oh HK, Dienst S, Levin NW.
    Transplant Proc; 1987 Feb 22; 19(1 Pt 3):1882-5. PubMed ID: 3547893
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.